These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3168695

  • 41. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations.
    Delchier JC, Vidon N, Saint-Marc Girardin MF, Soule JC, Moulin C, Huchet B, Zylberberg P.
    Aliment Pharmacol Ther; 1991 Aug; 5(4):365-78. PubMed ID: 1777547
    [Abstract] [Full Text] [Related]

  • 42. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL.
    Int J Pancreatol; 1989 Aug; 5 Suppl():31-6. PubMed ID: 2702248
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Therapy with pancreatic enzyme preparations].
    Holtmann G, Layer P.
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract] [Full Text] [Related]

  • 45. Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy.
    Ihse I, Lilja P, Lundquist I.
    Scand J Gastroenterol; 1980 Feb; 15(2):137-44. PubMed ID: 6155686
    [Abstract] [Full Text] [Related]

  • 46. Pancreatic enzyme replacement therapy in post-pancreatectomy patients.
    Braga M, Cristallo M, De Franchis R, Mangiagalli A, Zerbi A, Agape D, Primignani M, Di Carlo V.
    Int J Pancreatol; 1989 Feb; 5 Suppl():37-44. PubMed ID: 2702249
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
    Bruno MJ, Borm JJ, Hoek FJ, Delzenne B, Hofmann AF, de Goeij JJ, van Royen EA, van Gulik TM, de Wit LT, Gouma DJ, van Leeuwen DJ, Tytgat GN.
    Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133
    [Abstract] [Full Text] [Related]

  • 49. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future.
    George DE, Mangos JA.
    J Pediatr Gastroenterol Nutr; 1988 Jul; 7 Suppl 1():S49-57. PubMed ID: 3042940
    [No Abstract] [Full Text] [Related]

  • 50. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B, Ivaldi AP.
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [Abstract] [Full Text] [Related]

  • 51. Two enteric coated microspheres in cystic fibrosis.
    Williams J, MacDonald A, Weller PH, Fields J, Pandov H.
    Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F, O'Keefe SJ, Marks IN, Girdwood A, Young G.
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F.
    Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Medical treatment of pancreatic insufficiency.
    DiMagno EP.
    Mayo Clin Proc; 1979 Jul; 54(7):435-42. PubMed ID: 36518
    [Abstract] [Full Text] [Related]

  • 58. Exocrine pancreatic insufficiency in a cat.
    Browning T.
    Aust Vet J; 1998 Feb; 76(2):104-6. PubMed ID: 9578779
    [No Abstract] [Full Text] [Related]

  • 59. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
    Thorat V, Reddy N, Bhatia S, Bapaye A, Rajkumar JS, Kini DD, Kalla MM, Ramesh H.
    Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.